ERDHEIM-CHESTER DISEASE
Clinical trials for ERDHEIM-CHESTER DISEASE explained in plain language.
Never miss a new study
Get alerted when new ERDHEIM-CHESTER DISEASE trials appear
Sign up with your email to follow new studies for ERDHEIM-CHESTER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a melanoma drug combo work for other rare cancers? new trial aims to find out
Disease control Recruiting nowThis trial tests whether a combination of two drugs, vemurafenib and cobimetinib, can shrink or control rare cancers that have a specific BRAF V600 mutation. The drugs are already approved for melanoma, and researchers want to see if they help people with other cancer types, like…
Matched conditions: ERDHEIM-CHESTER DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New hope for rare immune disorders: targeted pill shows promise
Disease control Recruiting nowThis study tests a drug called cobimetinib in children and adults with Langerhans cell histiocytosis (LCH) and related disorders that have not responded to standard treatment. Cobimetinib blocks a faulty growth signal in the cells causing the disease. The goal is to shrink tumors…
Matched conditions: ERDHEIM-CHESTER DISEASE
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New PET scan tracer could spot hidden cancers
Knowledge-focused Recruiting nowThis early-phase study is testing a new imaging agent called [68Ga]-pentixafor to see how well it lights up certain blood cancers and related disorders on PET/CT scans. About 30 adults with non-Hodgkin lymphoma, multiple myeloma, or histiocytic neoplasms will receive the agent an…
Matched conditions: ERDHEIM-CHESTER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 08:50 UTC
-
Researchers launch registry to track rare histiocytosis diseases
Knowledge-focused Recruiting nowThis study creates a registry for up to 500 people with Erdheim-Chester disease and other histiocytoses. Researchers will collect health information, treatment details, and patient experiences over time to better understand these rare conditions. Some participants may also be ask…
Matched conditions: ERDHEIM-CHESTER DISEASE
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC